NCT05198050View on ClinicalTrials.gov

Letrozole in Induction of Abortion of Anembryonic Pregnancy

NACompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

April 3, 2022

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions
Anembryonic Pregnancy
Interventions
DRUG

Letrozole tablets

Letrozole is a third-generation non-steroidal aromatase inhibitor

DRUG

Misoprostol Tabets

a synthetic prostaglandin medication

DRUG

Placebo tablets

Placebo tables with a similar appearance to letrozole

Trial Locations (1)

12613

Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER